VIELABIO Trademark

Trademark Overview

On Wednesday, October 10, 2018, a trademark application was filed for VIELABIO with the United States Patent and Trademark Office. The USPTO has given the VIELABIO trademark a serial number of 88149113. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 19, 2025. This trademark is owned by VIELA BIO, INC.. The VIELABIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of inflammation and autoimmune diseases; clinical trials for others in the field of inflammation and autoimmune diseases
vielabio

General Information

Serial Number88149113
Word MarkVIELABIO
Filing DateWednesday, October 10, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 19, 2025
Registration Number5691887
Registration DateTuesday, March 5, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements

Description of MarkThe mark consists of multiple lines in geometrical style with word "VIELABIO" in stylized form on the right side.
Pseudo MarkVIELA BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the field of inflammation and autoimmune diseases; clinical trials for others in the field of inflammation and autoimmune diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 19, 2025
Primary Code042
First Use Anywhere DateFriday, February 23, 2018
First Use In Commerce DateFriday, February 23, 2018

Trademark Owner History

Party NameVIELA BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameVIELA BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameVIELA BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Saturday, October 13, 2018NEW APPLICATION ENTERED
Friday, October 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 6, 2018ASSIGNED TO EXAMINER
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 20, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 31, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 19, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 19, 2025CANCELLED SEC. 8 (6-YR)
Wednesday, February 19, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

vielabio diseases inflammation autoimmune field others trials development research clinical